Fabrice Morel

4.5k citations
51 papers · 3.6k indexed · 1 hit paper · h-index 32

Impact in

  • Pharmacology top 0.1%
    • Pharmacogenetics and Drug Metabolism
    • Drug-Induced Hepatotoxicity and Protection
  • Hepatology top 1%
    • Liver physiology and pathology

Papers in

    • Pharmacogenetics and Drug Metabolism 16
    • Drug-Induced Hepatotoxicity and Protection 11

Fabrice Morel

51 papers receiving 3.5k citations

Hit Papers

EXPRESSION OF CYTOCHROMES P450, CONJUGATING ENZYMES AND NUCLEAR RECEPTORS IN HUMAN HEPATOMA HepaRG CELLS 2005 · 533 citations
5332005202620122019100200300400500

Peers

Fabrice Morel
Comparison fields: 5 of 124
  • Pharmacology 1.2k
  • Hepatology 614
  • Cancer Research 430
  • Oncology 683
  • Molecular Biology 1.7k
Replace Roque Bort with:
Roque Bort Spain
M. José Gómez‐Lechón Spain
Sophie Langouët France
Caroline Aninat France
Ramiro Jover Spain
Lysiane Richert France
A. Guillouzo France
José E. Manautou United States
Jonathan Maher United States
Martine Daujat‐Chavanieu France
Fabrice Morel relative to Roque Bort Spain Roque Bort's profile →
Citations per field
00.5×1.5×
Roque Bort · 1×
Citations per year

Countries citing papers authored by Fabrice Morel

Since Specialization
Citations

This map shows the geographic impact of Fabrice Morel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabrice Morel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabrice Morel more than expected).

Fields of papers citing papers by Fabrice Morel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabrice Morel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabrice Morel. The network helps show where Fabrice Morel may publish in the future.

Co-authors

The 25 scholars most cited alongside Fabrice Morel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Fabrice Morel Line = papers co-authored together Fabrice Morel links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 201952
2 20174
3 201617
4 201536
5 200912
6 200937
7 200993
8 200950
9 200765
10 200510
11 2004125
12 200332
13 200341
14 200298
15 199825
16 19969
17 199023
18 199040
19 198917
20 198928

About Fabrice Morel

Fabrice Morel is a scholar working on Pharmacology, Aging, Hepatology, Biochemistry and Molecular Biology, having authored 51 papers that have together received 3.6k indexed citations. Recurring topics across this work include Glutathione Transferases and Polymorphisms (23 papers), Genomics, phytochemicals, and oxidative stress (23 papers), Pharmacogenetics and Drug Metabolism (16 papers), Drug-Induced Hepatotoxicity and Protection (11 papers), Drug Transport and Resistance Mechanisms (9 papers), Liver physiology and pathology (6 papers), Eicosanoids and Hypertension Pharmacology (3 papers) and Estrogen and related hormone effects (3 papers). The work is most often cited by research in Pharmacology (1.2k citations), Hepatology (614 citations), Cancer Research (430 citations), Oncology (683 citations) and Molecular Biology (1.7k citations). Fabrice Morel has collaborated with scholars based in France, United States and Japan. Frequent co-authors include André Guillouzo, Caroline Aninat, Denise Glaise, Christiane Guguen‐Guillouzo, Anne Corlu, Claudine Rauch, Sophie Langouët, Amélie Piton, Brian Coles and Damrong Ratanasavanh. Their work appears in journals such as Journal of Biological Chemistry, FEBS Letters, Hepatology, European Journal of Biochemistry and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026